Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Efficacy and safety of long-term (>7 year) alemtuzumab therapy for refractory T-cell large granular lymphocytic leukaemia. Br J Haematol 2010 Aug;150(4):480-1

Date

05/12/2010

Pubmed ID

20456357

DOI

10.1111/j.1365-2141.2010.08218.x

Scopus ID

2-s2.0-77955163811 (requires institutional sign-in at Scopus site)   3 Citations

Author List

Olteanu H, Harrington AM, Ramirez S, Kroft SH, Hari P

Authors

Parameswaran Hari MD Adjunct Professor in the Medicine department at Medical College of Wisconsin
Alexandra M. Harrington MD Professor in the Pathology department at Medical College of Wisconsin
Steven Howard Kroft MD Chair, Professor in the Pathology department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Alemtuzumab
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm
Antineoplastic Agents
Drug Administration Schedule
Female
Humans
Leukemia, Large Granular Lymphocytic
Middle Aged
Purpura, Thrombocytopenic, Idiopathic